Differential Scanning Calorimetry of Chloramphenicol Palmitate and the Phase-Transitional Behavior of Chloramphenicol Palmitate observed during the Preparation of Its Oral Suspension
スポンサーリンク
概要
- 論文の詳細を見る
Differential scanning calorimetry was carried out to elucidate the properties of two metastable forms of chloramphenicol palmitate (δ form and sub-α form) and the occurrence and the role of the sub-α form during manufacturing of chloramphenicol palmitate oral suspension. The δ form, a new form, was obtained when the small amount of melted chloramphenicol palmitate was cooled very rapidly to below 0° and it was converted to the sub-α form at 23° on heating. The X-ray diffraction pattern of the δ form was distinguished from that of any other forms reported. The other form, sub-α, was obtained by warming the δ form or directly from the melt by rapid cooling. It was transformed to the α form while liberating heat from about 40° through about 75°. The X-ray diffraction pattern, infrared absorption spectra, the behavior in the hot stage of the polarizing microscope and the differential scanning calorimetric curves suggested that the sub-α form is composed of the crystallites of the α form. Estimated thermodynamic values at the 95% confidence limit were ; ΔH_<melt→sub-α>=-9.2±0.2kcal/mole, ΔH_<melt→δ>=-2.8±0.5 kcal/mole, ΔH_<δ→sub-a>=-2.2±0.7 kcal/mole, and ΔH_<sub-α→α>=-2.0±0.3 (the sub-α form directly form the melt) and -6.1±0.9 kcal/mole (the sub-α form via the δ form). The supercooled dispersion of chloramphenicol palmitate in the emulsifier solution turned into the suspension while stirring. The first solid state of the chloramphenicol palmitate was estimated to be the sub-α form and it was transformed to the α-form gradually.
- 公益社団法人日本薬学会の論文
- 1973-09-25
著者
-
前田 忠男
Formulation Research Department, Pharmaceuticals Division, Sumitomo Chemical Co., Ltd.
-
前田 忠男
Formulation Research Department Pharmaceuticals Division Sumitomo Chemical Co. Ltd.
-
清滝 友昭
Formulation Research Department Ibaraki Plant Pharmaceuticals Division Sumitomo Chemical Co. Ltd.
-
宮本 正敏
Formulation Research Department, Ibaraki Plant, Pharmaceuticals Division, Sumitomo Chemical Co., Ltd
-
競 奈尾
Formulation Research Department, Ibaraki Plant, Pharmaceuticals Division, Sumitomo Chemical Co., Ltd
-
光長 孝義
Formulation Research Department, Ibaraki Plant, Pharmaceuticals Division, Sumitomo Chemical Co., Ltd
-
宮本 正敏
Formulation Research Department Ibaraki Plant Pharmaceuticals Division Sumitomo Chemical Co. Ltd.
-
競 奈尾
Formulation Research Department Ibaraki Plant Pharmaceuticals Division Sumitomo Chemical Co. Ltd.
-
光長 孝義
Formulation Research Department Ibaraki Plant Pharmaceuticals Division Sumitomo Chemical Co. Ltd.
関連論文
- Significance of Stomach-Emptying-Controlled Rabbits for GI Absorption Studies of Water-Soluble Drugs
- Lipid-Containing Oral Dosage Form : Significance of the Intragastric Metabolism of Medium Chain Triglyceride in Relation to the Uniformity of Drug Absorption Rate
- Absorption of Diazepam from a Lipid-Containing Oral Dosage Form
- Use of Rabbits for Absorption Studies on Polymorphs of Chloramphenicol Palmitate
- Use of Rabbits for GI Drug Absorption Studies : Physiological Study of Stomach-Emptying Controlled Rabbits
- Differential Scanning Calorimetry of Chloramphenicol Palmitate and the Phase-Transitional Behavior of Chloramphenicol Palmitate observed during the Preparation of Its Oral Suspension
- Hydrolytic and Associative Behavior of Aromatic Amides in Aqueous Solution
- Thermal Behavior of the Delta Form of Chloramphenicol Palmitate
- Studies on Powdered Preparations. IX. Thermal Analysis of the Velocity of Reaction between Dried Aluminum Hydroxide Gel and Acid.
- Studies on Powdered Preparations. XX. Disintegration of the Aspirin Tablets containing Starches as Disintegrating Agent
- Studies on Molecular Interaction in Solution. III. Salting Behavior of Cyclic Amides and Cyclic Conjugated Ketones in Tetraalkylammonium Salt Solutions
- Studies on Molecular Interaction in Solution. I. Effects of Organic Ions on the Solubility of 8-Methoxycaffeine